[Clinical use of factor IX concentrates].
Factor IX concentrates are of paramount importance in the treatment of hemophilia B. Growing reports of thromboembolic complications and of disseminated intravascular coagulation, coupled with the danger of hepatitis transmission, suggest that the concentrates should be primarily reserved for the treatment of hemophilia B. Concise guidelines for treatment are presented.
D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced; D005164:Factor IX / Q000009:adverse effects / Q000627:therapeutic use*; D002836:Hemophilia B / Q000628:therapy; D006505:Hepatitis / Q000635:transmission; D006801:Humans; D013923:Thromboembolism / Q000139:chemically induced
D005164:Factor IX
Klinische Verwendung von Faktor-IX-Konzentraten